Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Solid Tumor Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Solid Tumor Therapeuticsmarket, defines the market attractiveness level of Solid Tumor Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Solid Tumor Therapeutics industry, describes the types of Solid Tumor Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Solid Tumor Therapeutics market and the development prospects and opportunities of Solid Tumor Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Solid Tumor Therapeutics market in Chapter 13.
By Player:
Abbott Laboratories
Novartis
Johnson & Johnson
Biogen Idec
Baxter International
Boehringer Ingelheim
Kyowa Hakko Kirin
AstraZeneca
Hoffmann-La Roche
GlaxoSmithKline
Eli Lilly
By Type:
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy
By End-User:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Solid Tumor Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Solid Tumor Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Solid Tumor Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Solid Tumor Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Solid Tumor Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Solid Tumor Therapeutics Consumption (2017-2022)
-
7.2 United States Solid Tumor Therapeutics Consumption (2017-2022)
-
7.3 Europe Solid Tumor Therapeutics Consumption (2017-2022)
-
7.4 China Solid Tumor Therapeutics Consumption (2017-2022)
-
7.5 Japan Solid Tumor Therapeutics Consumption (2017-2022)
-
7.6 India Solid Tumor Therapeutics Consumption (2017-2022)
-
7.7 South Korea Solid Tumor Therapeutics Consumption (2017-2022)
8 Region and Country-wise Solid Tumor Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Solid Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Solid Tumor Therapeutics Consumption Forecast (2022-2028)
9 Global Solid Tumor Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Solid Tumor Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Solid Tumor Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cervical Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Solid Tumor Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Solid Tumor Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Solid Tumor Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Solid Tumor Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Solid Tumor Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Solid Tumor Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Solid Tumor Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Solid Tumor Therapeutics Market Competitive Analysis
-
14.1 Abbott Laboratories
-
14.1.1 Abbott Laboratories Company Details
-
14.1.2 Abbott Laboratories Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Laboratories Solid Tumor Therapeutics Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Solid Tumor Therapeutics Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Solid Tumor Therapeutics Product and Service
-
14.4 Biogen Idec
-
14.4.1 Biogen Idec Company Details
-
14.4.2 Biogen Idec Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Idec Solid Tumor Therapeutics Product and Service
-
14.5 Baxter International
-
14.5.1 Baxter International Company Details
-
14.5.2 Baxter International Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Baxter International Solid Tumor Therapeutics Product and Service
-
14.6 Boehringer Ingelheim
-
14.6.1 Boehringer Ingelheim Company Details
-
14.6.2 Boehringer Ingelheim Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Product and Service
-
14.7 Kyowa Hakko Kirin
-
14.7.1 Kyowa Hakko Kirin Company Details
-
14.7.2 Kyowa Hakko Kirin Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Solid Tumor Therapeutics Product and Service
-
14.9 Hoffmann-La Roche
-
14.9.1 Hoffmann-La Roche Company Details
-
14.9.2 Hoffmann-La Roche Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Hoffmann-La Roche Solid Tumor Therapeutics Product and Service
-
14.10 GlaxoSmithKline
-
14.10.1 GlaxoSmithKline Company Details
-
14.10.2 GlaxoSmithKline Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline Solid Tumor Therapeutics Product and Service
-
14.11 Eli Lilly
-
14.11.1 Eli Lilly Company Details
-
14.11.2 Eli Lilly Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Eli Lilly Solid Tumor Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Solid Tumor Therapeutics
-
Figure Solid Tumor Therapeutics Picture
-
Table Global Solid Tumor Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Solid Tumor Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Solid Tumor Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Solid Tumor Therapeutics Consumption by Country (2017-2022)
-
Figure United States Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Solid Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Solid Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Solid Tumor Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Solid Tumor Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Solid Tumor Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Solid Tumor Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Solid Tumor Therapeutics Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Solid Tumor Therapeutics Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Solid Tumor Therapeutics Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Solid Tumor Therapeutics Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Solid Tumor Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Solid Tumor Therapeutics Product and Service
-
Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Solid Tumor Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Solid Tumor Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Solid Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Solid Tumor Therapeutics Product and Service
-
